{
    "SPADE_N_14467": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14467",
            "Peptide Name": "RH-16 (Synthetic AMPs, RG-29 fragment, XXA, UCLL1c)",
            "Source": "amino acid truncation, reptile cathelicidin fragment, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RWRRFWGKAKRGIKKH",
            "Sequence Length": 16,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2110.52,
            "PI": 12.0,
            "Hydrophobicity": -1.89,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Cai Y, Wang X, Zhang T, Yan A, Luo L, Li C, Tian G, Wu Z, Wang X, Shen D, Han Y, Zhang Z. 2024",
                    "Reference": "ACS Infect Dis. 2024 Mar 8;10(3):951-960. doi: 10.1021/acsinfecdis.3c00575.PubMed",
                    "Title": "Rational Design of a Potent Antimicrobial Peptide Based on the Active Region of a Gecko Cathelicidin."
                }
            ],
            "Frequent Amino Acids": "KRG",
            "Absent Amino Acids": "CDELMNOPQSTUVY",
            "Basic Residues": 9,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 10,
            "Positive Residues": 9,
            "Negative Residues": 0,
            "Net Charge": 9,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (55.17%) toRG-29K=R: 22%; G: 17%.Activity: active against A. baumannii ATCC19606 and 3 clinical strains (MIC 4.69-9.38 ug/ml), E. coli ATCC8739 and 3 clinical strains (MIC 4.69-9.38 ug/ml), P. aeruginosa ATCC27853 and 4 clinical strains (MIC 2.34-9.38 ug/ml), and S. aureus ATCC6538 and 7 clinical strains (MIC 2.34-4.69 ug/ml). Warning: Non-standard assay.Structure:  random coil in aqueous solution and helical in 30 mM SDS.In vitro toxicity: showed minimal hemo.lytic till 100 ug/ml and little toxicity to HaCaT and HEK293 cells.In vivo toxicity: 10 mg/kg IV: no observable toxicity within 48 h; mild toxicity at 20 mg/kg.Animal model:mouse: wound skin infection model:S. aureus or A. baumannii: treatment with peptide up to 2 mg/ml led to 84.2% CFU decrease (not as good as colistin at 0.5 mg/ml or vancoumycin at 0.5 mg/ml.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02450",
                    "Similarity": 1.0,
                    "Sequence": "NPLSCRLNRGICVPIRCPGNLRQIGTCFTPSVKCCRWR"
                },
                {
                    "SPADE_ID": "SPADE_N_03976",
                    "Similarity": 1.0,
                    "Sequence": "GISNPLSCRLNRGICVPIRCPGNLRQIGTCFTPSVKCCRWR"
                },
                {
                    "SPADE_ID": "SPADE_N_08041",
                    "Similarity": 1.0,
                    "Sequence": "MRLHHLLLTLLFLVLSAGSGFTQGISNPLSCRLNRGICVPIRCPGNLRQIGTCFTPSVKCCRWR"
                }
            ]
        }
    }
}